Conway, K., Edmiston, S. N., Vondras, A., Reiner, A., Corcoran, D. L., Shen, R., Parrish, E. A., Hao, H., Lin, L., Kenney, J. M., Ilelaboye, G., Kostrzewa, C. E., Kuan, P. F., Busam, K. J., Lezcano, C., Lee, T. K., Hernando, E., Googe, P. B., Ollila, D. W., … Rainka, M. (2024). DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precision Oncology, 8. https://doi.org/10.1200/po-24-00375

Jain, S., Bai, X., Mallick, S., Kinghorn, B., May, B., Yao, A. G., Allen-Gipson, D., Zhang, X., Henick, B. S., Momen-Heravi, F., Carrot-Zhang, J., & Taylor, A. M. (2024). Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma. JCO Precision Oncology, 8. https://doi.org/10.1200/po.24.00223

Henick, B. S., & Moy, R. H. (2024). TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer. JCO Precision Oncology, 8. https://doi.org/10.1200/po.24.00344

Lenis, A. T., Whiting, K., Ravichandran, V., Tallman, J. E., Alam, S. M., Chu, C. E., Jesus Escano, M. D., Bochner, E., Katims, A., Reisz, P. A., Truong, H., Clinton, T. N., Telis, L., Dason, S., McPherson, V., Teo, M. Y., Funt, S., Aggen, D., Goh, A. C., … Pietzak, E. J. (2024). Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer. JCO Precision Oncology, 8. https://doi.org/10.1200/po.23.00274

Thummalapalli, R., Bernstein, E., Herzberg, B., Li, B. T., Iqbal, A., Preeshagul, I., Santini, F. C., Eng, J., Ladanyi, M., Yang, S.-R., Shen, R., Lito, P., Riely, G. J., Sabari, J. K., & Arbour, K. C. (2023). Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non–Small Cell Lung Cancer. JCO Precision Oncology, 7. https://doi.org/10.1200/po.23.00030

Brett, J. O., Dubash, T. D., Johnson, G. N., Niemierko, A., Mariotti, V., Kim, L. S. L., Xi, J., Pandey, A., Dunne, S., Nasrazadani, A., Lloyd, M. R., Kambadakone, A., Spring, L. M., Micalizzi, D. S., Onozato, M. L., Che, D., Nayar, U., Brufsky, A., Kalinsky, K., … Wander, S. A. (2023). A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO Precision Oncology, 7. https://doi.org/10.1200/po.22.00532

Tshiaba, P. T., Ratman, D. K., Sun, J. M., Tunstall, T. S., Levy, B., Shah, P. S., Weitzel, J. N., Rabinowitz, M., Kumar, A., & Im, K. M. (2023). Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification. JCO Precision Oncology, 7. https://doi.org/10.1200/po.22.00447

Cuppen, E., Elemento, O., Rosenquist, R., Nikic, S., IJzerman, M., Zaleski, I. D., Frederix, G., Levin, L.-Å., Mullighan, C. G., Buettner, R., Pugh, T. J., Grimmond, S., Caldas, C., Andre, F., Custers, I., Campo, E., van Snellenberg, H., Schuh, A., Nakagawa, H., … Jobanputra, V. (2022). Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care. JCO Precision Oncology, 6. https://doi.org/10.1200/po.22.00245

Bose, S., Lee, T., Choi, S., Fazlollahi, L., Rasiej, M. J., Schwartz, G. K., & Ingham, M. (2022). CDK4/6 Inhibition With Anti–PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD–1 Alone. JCO Precision Oncology, 6. https://doi.org/10.1200/po.21.00550

Moy, R. H., Walch, H. S., Mattar, M., Chatila, W. K., Molena, D., Strong, V. E., Tang, L. H., Maron, S. B., Coit, D. G., Jones, D. R., Hechtman, J. F., Solit, D. B., Schultz, N., de Stanchina, E., & Janjigian, Y. Y. (2022). Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts. JCO Precision Oncology, 6. https://doi.org/10.1200/po.21.00242

Doshi, S. D., Oza, J., Remotti, H., Remotti, F., Moy, M. P., Schwartz, G. K., & Ingham, M. (2021). Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated Sarcoma. JCO Precision Oncology, 5, 1–5. https://doi.org/10.1200/po.20.00201

Dowlati, A., Abbas, A., Chan, T., Henick, B., Wang, X., Doshi, P., Fu, P., Patel, J., Kuo, F., Chang, H., & Balli, D. (2022). Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function. JCO Precision Oncology, 6. https://doi.org/10.1200/po.22.00257